Winton Group’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$83.8K Buy
+14,067
New +$66.7K ﹤0.01% 1044

Other funds holding CTKB

Winton Group's CTKB Position: Q3 2026 in Review

Winton Group opened a new position in Cytek Biosciences (CTKB) in Q3 2026: 14,067 shares worth $83.8K. The stake represents ﹤0.01% of the portfolio and ranks #1044 among its holdings.

150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Winton Group held 14,067 shares of Cytek Biosciences worth $83.8K as of Q3 2026.
  • Cytek Biosciences was a new Winton Group position in Q3 2026.
  • Cytek Biosciences made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1044 holding.
  • 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.